Day: July 21, 2020

CAMBRIDGE, Mass., July 21, 2020 (GLOBE NEWSWIRE) — Biogen Inc. (Nasdaq: BIIB) announced today the appointment of Michael (Mike) McDonnell as Executive Vice President and Chief Financial Officer, effective August 15, 2020. McDonnell joins Biogen from IQVIA™ (NYSE: IQV), where he is Executive Vice President and Chief Financial Officer. At Biogen, McDonnell will lead the global finance function and operations, the Company’s shared services center, information technology and investor relations groups. He will report directly to Biogen’s Chief Executive Officer Michel Vounatsos, and will be based in Cambridge, Massachusetts.McDonnell brings an extensive background in strategic finance and operations, and experience in leading global teams from diverse industries. During his tenure at IQVIA, the company has become an industry leader in...

TORONTO, July 21, 2020 (GLOBE NEWSWIRE) — Skyline Investments Inc. (the “Company” or “Skyline”) (TASE: SKLN) announces the following:Effective July 20, 2020, Mr. Blake Lyon, the Company’s Chief Executive Officer and a Canadian resident, has been appointed a director of the Company to fill the vacancy created by the resignation of Mr. Gil Blutrich as a director on July 15, 2020.  Mr. Lyon will serve as a director for a term expiring at the Company’s 2020 annual meeting of shareholders. The Board, through its Governance and Nominating Committee, will continue to conduct its thorough process for determining a slate of directors to be nominated for election at the Company’s 2020 annual meeting of shareholders.           About SkylineSkyline is a Canadian company that specializes in hospitality real estate investments in the United States...

YUBA CITY, Calif., July 21, 2020 (GLOBE NEWSWIRE) — River Valley Community Bancorp (OTC markets: RVCB) with its wholly owned subsidiary, River Valley Community Bank (collectively referred to as the “Bank”), today announced financial results for the quarter ended June 30, 2020.Consolidated financial highlights:Total assets crossed the $500 million threshold for the first time in the Bank’s history and totaled $514.8 million as of June 30, 2020 compared to $402.7 million as of June 30, 2019 and $468.7 million as of March 31, 2020.  Much of the second quarter growth was attributable to loans originated under the federal government’s Paycheck Protection Program (PPP).Net income for the quarter ended June 30, 2020 totaled $652,000 or $0.27 per diluted share compared to $1.4 million or $0.55 per diluted share for the quarter ended June...

NEW YORK, July 21, 2020 (GLOBE NEWSWIRE) — Mesoblast Limited (Nasdaq:MESO; ASX:MSB) today announced that the Oncologic Drugs Advisory Committee (ODAC) of the United States Food and Drug Administration (FDA) has scheduled a meeting on August 13, 2020 to review data supporting the Company’s Biologics License Application (BLA) for approval of RYONCIL™ (remestemcel-L) for the treatment of steroid-refractory acute graft versus host disease (SR-aGVHD) in children.There are currently no FDA-approved treatments in the United States for children under 12 with SR-aGVHD, a potentially life-threatening complication of an allogeneic bone marrow transplant for blood cancer. RYONCIL is under Priority Review by the FDA with an action date of September 30, 2020, under the Prescription Drug User Fee Act (PDUFA).The ODAC is an independent panel of...

All amounts in U.S. dollars unless otherwise stated TORONTO, July 21, 2020 (GLOBE NEWSWIRE) — Onex Corporation (“Onex”) (TSX: ONEX) confirms all nominees set forth in the management information circular for its July 21, 2020 Annual Meeting of Shareholders have been elected as directors of the Company.  Detailed results of the vote for each director are set out below.Onex also presented an advisory resolution to shareholders endorsing the Company’s approach to executive compensation, generally referred to as “say-on-pay”.  The Company is pleased to report the advisory resolution passed overwhelmingly with 96.23% support.Finally, Onex shareholders confirmed almost unanimously a by-law adopted by Onex in connection with its acquisition of WestJet in December 2019 related to ensuring Canadian ownership and control of WestJet.About ...

SECOND QUARTER 20201 HIGHLIGHTSGAAP diluted EPS was $0.63, compared to ($0.05) in 1Q20 and $0.37 in 2Q19Core diluted EPS was $0.36 compared to $0.19 in 1Q20 and $0.42 in 2Q19Net interest margin was 2.87%, up 43bps QoQ and 42bps YoYCore net interest margin was 2.85%, up 36bps QoQ and 45bps YoYRecord GAAP net interest income of $48.7 million, up 19.3% QoQ and 21.8% YoYRecord Core net interest income of $49.1 million, up 14.4% QoQ and 20.2% YoYGAAP and core ROAE 13.1% and 7.4%, respectively, compared with (1.0)% and 3.8%, respectively in 1Q20GAAP and core ROAA were 1.0% and 0.6%, respectively, compared with (0.1)% and 0.3%, respectively in 1Q20Loan pipeline remains strong at $310.8 millionProvision for credit losses of $9.6 million, $0.25 after-tax per diluted common share, driven mainly by economic conditions arising from COVID-19 pandemicNet...

CHICAGO, July 21, 2020 (GLOBE NEWSWIRE) — First Midwest Bancorp, Inc. (the “Company” or “First Midwest”), the holding company of First Midwest Bank (the “Bank”), today reported results of operations and financial condition for the second quarter of 2020. Net income applicable to common shares for the second quarter of 2020 was $17.8 million, or $0.16 per share, compared to $19.4 million, or $0.18 per share, for the first quarter of 2020, and $46.6 million, or $0.43 per share, for the second quarter of 2019.Results for the second and first quarters of 2020 were impacted by the COVID-19 pandemic (the “pandemic”) and governmental responses to it, resulting in higher provision for loan losses, as well as lower net interest and noninterest income. In addition, the adoption of the current...

GOLDEN, Colo., July 21, 2020 (GLOBE NEWSWIRE) — Golden Minerals Company (NYSE American and TSX: AUMN) (“Golden Minerals”, “Golden” or “the Company”) announced today that it has entered into an underwriting agreement with H.C. Wainwright & Co. under which the underwriter has agreed to purchase on a firm commitment basis 15,476,191 shares of common stock of the Company, at a price to the public of $0.42 per share, less customary underwriting discounts and commissions. The closing of the offering is expected to occur on or about July 23, 2020, subject to satisfaction of customary closing conditions.H.C. Wainwright & Co. is acting as the sole book-running manager for the offering.The Company also has granted to the underwriter a 30-day option to purchase up to an additional 2,321,428 shares of common stock at the public offering...

MALVERN, Pa., July 21, 2020 (GLOBE NEWSWIRE) — Ocugen, Inc. (NASDAQ: OCGN), a biopharmaceutical company focused on discovering, developing, and commercializing transformative therapies to treat rare and underserved ophthalmic diseases, today announced it will present at the World Orphan Drug Congress USA 2020 Conference, to be held virtually from August 24-27, 2020.Rasappa Arumugham, PhD, Chief Scientific Officer of Ocugen, will highlight Ocugen’s breakthrough modifier gene therapy platform as part of the Next Generation Therapies Seminar.Presentation Details:Date: Monday, August 24, 2020Time: 1:00 PM (Eastern Time)Website: https://www.terrapinn.com/conference/world-orphan-drug-congress-usa/index.stmAbout Ocugen, Inc.Ocugen, Inc. is a biopharmaceutical company focused on discovering, developing, and commercializing transformative...

CALGARY, Alberta, July 21, 2020 (GLOBE NEWSWIRE) — Parkland Corporation (“Parkland”) (TSX:PKI) expects to announce its 2020 second quarter results after markets close on Thursday, August 6, 2020. A conference call and webcast will then be held at 6:30 a.m. MDT (8:30 a.m. EDT) on Friday, August 7, 2020, to discuss the results. To listen to the live webcast and watch the presentation, please use the following link:https://produceredition.webcasts.com/starthere.jsp?ei=1345078&tp_key=a86f827043Analysts and institutional investors interested in participating in the question and answer session of the conference call may do so by calling 1-888-390-0546 (toll-free) (Conference ID: 51995975).Please connect and log in approximately 10 minutes before the beginning of the call. The webcast will be available for replay two hours after the...